Novel Mechanisms Underlying Immune-Checkpoint Inhibitors-Related Diabetes and Resistance in Cancer Treatment London South Bank University (LSBU) in United Kingdom

A fantastic opportunity for postdoctoral researchers interested in molecular biodiscovery at the University of Birmingham . The MOBILITY opportunity offers six outstanding postdoctoral researchers a five-year chance to develop their own ambitious research programme and build the skills, experience, and profile needed to become the next generation of research leaders. This is a strong fit for researchers with interests in biology , chemistry , medical science , and related areas of molecular disc...

University of Oxford is advertising a Postdoctoral Research Scientist position in the CAMS Oxford Institute , working with Professor Tao Dong in the Cancer Immunology and Immunotherapy group . The project focuses on identifying and characterising cancer-specific T cells that may cross-react with viral antigens, with the broader goal of improving understanding of cancer progression and informing new cancer immunotherapy strategies. The role includes designing and conducting experiments, analysing...

King's College London is offering a PhD studentship in the United Kingdom, open to candidates with an MSc or MRes in microbiology, biomedical science, chemistry, or biology. This opportunity is ideal for graduates with strong research experience, particularly those who have demonstrated their skills through a dissertation. The studentship is situated within the life sciences and healthcare research domain, providing a platform for advanced study and research in microbiology, biomedical science, ...

University of Oxford is advertising a Postdoctoral Research Scientist in Leukaemia and Tumour Immunology based in Oxford, England, United Kingdom . The project is led by Professor Paresh Vyas and focuses on leukaemia, tumour immunology, AML, alloimmunity, cancer biology, T cell receptors, and structural biology . The research aims to identify mechanisms of alloimmune responses, discover tumour-specific alloimmune targets, define HLA-restricted peptide targets, dissect tumour cell killing, and so...

Queen Mary University of London is advertising a 42-month Postdoctoral Research Associate position in the Nicholson Lab in London, United Kingdom. The project focuses on glioblastoma , with an emphasis on how epigenetic heterogeneity and epigenetic plasticity contribute to treatment resistance and recurrence. The successful candidate will work with patient-derived models , single-cell epigenomics , and organoid co-cultures to help understand and ultimately target glioblastoma recurrence. This is...